ICT Module VI
Upon completion of the module, the participant will:
- Recognize Hoxsey therapy
- Understand Burzynski's anitneoplastons
- Know avemar therapy
- Understand protocell therapy
- Comprehend hyperbaric oxygen therapy
- Identify photodynamic treatment
- Learn sonodynamic therapy
- Study cancer pH manipulation therapy
- Learn about mind/body medicine
- Comprehend the significance of exercise as related to cancer therapies
- Learn about bio-oxidative and ultraviolet medicine and cancer therapies
- Discover IV vitamin C as a cancer treatment modality
Schedule:
| Hyperbaric Oxygen Therapies | Mark Rosenberg, MD |
| Antineoplastons, Chemistry, Mechanism of Action, Design, and Criticism of Clinical Trials | Stanislaw R. Burzynski, MD, PhD |
| Prospective Clinical Trials with Antineoplastons for Inoperable Brain Tumors in Children | Stanislaw R. Burzynski, MD, PhD |
| Phase 2 Prospective Clinical Trials for Inoperable Brain Tumors in Adults | Stanislaw R. Burzynski, MD, PhD |
| Vitamin C and Cancer- History and The Next Generation | Michael Gonzalez, PhD |
| Vitamin C and Cancer – The Scientific Basis for the use of Ascorbic Acid in Cancer | Michael Gonzalez, PhD |
| Vitamin C and Cancer – The RECNAC Protocol | Michael Gonzalez, PhD |
| Vitamin C and Cancer – The Systemic Saturation Concept and the Bioenergetic Theory of Carcinogenesis | Michael Gonzalez, PhD |
| Mind Body Medicine in Cancer Patients | Ines Alfaro, MD |
| Mind Body Medicine in Cancer Patients (Continued) | Ines Alfaro, MD |
| Evaluating the Evidence of Controversial Cancer Treatments | Dwight McKee, MD |
| Using Oxidative Therapies in a Cancer Management Protocol | Frank Shallenberger, MD |
| Using Oxidative Therapies in a Cancer Management Protocol | Frank Shallenberger, MD |
| Obesity, Exercise and Cancer Prevention | Pallav Mehta, MD |
| Exercise During and After Cancer Treatment | Pallav Mehta, MD |
| Cocktails Off-Label Drugs in Cancer Treatment Part II | Dwight McKee, MD |
| TK 1 and Cancer: A Novel Tumor Marker | Mark Rosenberg, MD |
| Gateby and Adaptive Therapy | Mark Rosenberg, MD |
